The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
Status:
Completed
Trial end date:
2021-02-23
Target enrollment:
Participant gender:
Summary
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Non-alcoholic fatty
liver disease (NAFLD) treatment drug HEC96719 in Healthy Male and Female Subjects